United Kingdom · 
Who invested in Calla Lily Clinical Care?
Calla Lily Clinical Care's investors include Innovate UK.
2023202420252026
$577KRound$490KRound$636KRound$992KRound$1.3MGrant$1.0MRound$1.4MRound
United Kingdom · Funded startup
Who invested in Calla Lily Clinical Care
Funding summaryUpdated 26 Oct 2026
$6.4Mraised across 7 rounds since 2022, from 7 sources
$577KRound$490KRound$636KRound$992KRound$1.3MGrant$1.0MRound$1.4MRound
- Latest round
- Round, $1.4MSept 2026
- Step-upi
- 1.3×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $577K Oct 2022
- Biggest round
- $1.4M Round · Sept 2026
- Usual gap between rounds
- 10 months the median of 6
The rounds
- Sept 2026Round$1.4M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Nov 2025Round$1.0M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Apr 2025
- Apr 2024Round$992K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Dec 2023Round$636K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Dec 2022Round$490K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Oct 2022Round$577K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Calla Lily Clinical Care filed 13 raises, $7.1M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Sept 2026$1.4MUK share allotment
- Dec 2025$516KUK share allotment
- Nov 2025$526KUK share allotment
- Apr 2025$339KUK share allotment
- Mar 2025$726KUK share allotment
- Dec 2024$942KUK share allotment
- Dec 2024Amount not statedUK share allotment
- Apr 2024$376KUK share allotment
- Apr 2024$616KUK share allotment
- Dec 2023$271KUK share allotment
- Dec 2023$365KUK share allotment
- Dec 2022$490KUK share allotment
- Oct 2022$577KUK share allotment
Founders and team
From Calla Lily Clinical Care's own website: 2 founders, 16 on the team.
Thang Vo-TaCo-founder & CEO
Dr Lara ZibnersCo-founder & Chairman
- Akeel KhanChief Product Officer
- Stuart PrinceChief Financial Officer
- Amy CoulsonBoard of directors
- Dr Arturo Jose Mendoza MeinhardtSenior Scientist
- Dr Elham ShiraniSenior Scientist
- Dr Emma ParryGP Researcher & PPIE Lead
- Dr Scheilly TsilovaSenior Pharmaceutical Scientist
- Dr Serena de GelidiR&D Manager
- Dr Yasmin FarhatniaR&D Manager
- Ewa RadziwonProduct Development Manager
- Kaylie MingsProject Manager
- Lia Mae PellegriniProduct Development Engineer
- Mark LubkemanBoard Director
- Prof Andrew LewisPrincipal Scientist
- Sabrina FrancoSenior Product & Quality Engineer
- Shaun KnightsOperations & Quality Director
AdvisersDr Alex HooiDr Ammara HughesDr James GrifoDr Janet HallidayDr Kelle MoleyDr Stuart LaveryProf David MacIntyre
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Calla Lily Clinical Care
How much has Calla Lily Clinical Care raised?
Calla Lily Clinical Care has raised $6.4M across 7 rounds since 2022.
When did Calla Lily Clinical Care last raise?
Calla Lily Clinical Care's most recent round, $1.4M, was in Sept 2026.
What was Calla Lily Clinical Care's biggest round?
Its most recent round, $1.4M in Sept 2026, is also its largest on record.
Who backed Calla Lily Clinical Care first?
Calla Lily Clinical Care's first round on record, in Apr 2025, was backed by Innovate UK.
What stage is Calla Lily Clinical Care at?
Calla Lily Clinical Care's latest named round is a Grant, in Apr 2025.
Where is Calla Lily Clinical Care based?
Calla Lily Clinical Care is based in the United Kingdom.
Companies like Calla Lily Clinical Care
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.